Aileron Therapeutics News

Aileron Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Cunningham Timothy M.

May 16 16:23

Aileron Therapeutics | 8-K: Current report

May 16 16:07

Aileron Therapeutics | 8-K: Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

May 15 16:22

Aileron Therapeutics | 10-Q: Quarterly report

May 15 16:13

Aileron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

May 14 16:55

Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

May 1 18:17

Aileron Therapeutics | 8-K: Current report

May 1 16:28

Aileron Therapeutics | 424B5: Prospectus

May 1 16:27

Aileron Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 1 16:18

Aileron Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

May 1 07:59

Aileron Therapeutics | 8-K: Current report

May 1 07:44

Aileron Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

Apr 30 14:37

Aileron Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 29 16:06

Aileron Therapeutics | 10-K/A: Annual report (Amendment)

Apr 29 07:37

Aileron Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Muneer A. Satter(4.9%)

Apr 16 16:21

Aileron Therapeutics | 8-K: Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Apr 15 16:25

Aileron Therapeutics | 10-K: Annual report

Apr 15 16:25

Aileron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director VON RICKENBACH JOSEF H

Apr 10 15:19

Aileron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Ambros Reinhard J.

Apr 10 15:18

Aileron Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Garner Charles

Apr 2 17:15